Novel drug combination unleashes apoptosis in AML

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


The combination of p53 activation and Bcl-2 inhibition reciprocally overcomes apoptosis resistance and leads to synergistic efficacy in acute myeloid leukemia.

Original languageEnglish (US)
Article numbereaar7509
JournalScience Translational Medicine
Issue number422
StatePublished - Jan 3 2018
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Novel drug combination unleashes apoptosis in AML'. Together they form a unique fingerprint.

Cite this